As the context of TGF-β signalling in this review relates to cardiac fibrosis/myopathy, chemotherapy and cancer it would be remiss not to discuss the tumor microenvironment, ECM and cancer-associated fibroblasts (CAFs) [102]. The gene discussed is TGFB1; the disease is neoplasm.